Emcure Pharma Q1 Net Profit Up 36% to ₹292.49 Crore

This story is about Emcure Pharmaceuticals, a company that makes medicines.

The company shared how much money it made in the first three months of its financial year, called Q1.

Its profit grew a lot compared with the same time last year, going up by 36.2%.

The company also earned more from selling its medicines, with revenue up 22.8%.

Sales in other countries grew especially fast and now bring in more than half of the company's income.

Emcure spent more on making and selling its products, which often happens when a business grows.

It also invested in research and development, which helps create new medicines in the future.

The company's Chairman, Berjis Desai, is retiring after the next shareholder meeting, and Satish Mehta will take over.

A new Chief Operating Officer for Emcure was also appointed.

These changes show the company is growing and getting ready for new leadership.